NORTHERN TRUST CORP - COHERUS BIOSCIENCES INC ownership

COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 202 filers reported holding COHERUS BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of COHERUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$3,599,170
+5.9%
962,345
+20.9%
0.00%0.0%
Q2 2023$3,399,932
-34.9%
796,237
+4.3%
0.00%0.0%
Q1 2023$5,223,490
-12.2%
763,668
+1.7%
0.00%0.0%
Q4 2022$5,948,078
-18.3%
751,020
-0.8%
0.00%
-50.0%
Q3 2022$7,277,000
+34.6%
757,124
+1.4%
0.00%
+100.0%
Q2 2022$5,407,000
-40.6%
746,844
+5.9%
0.00%
-50.0%
Q1 2022$9,104,000
-22.0%
705,200
-3.5%
0.00%0.0%
Q4 2021$11,668,000
-2.0%
731,102
-1.4%
0.00%0.0%
Q3 2021$11,912,000
+13.3%
741,234
-2.5%
0.00%0.0%
Q2 2021$10,516,000
-0.1%
760,409
+5.5%
0.00%0.0%
Q1 2021$10,531,000
-19.8%
720,775
-4.6%
0.00%
-33.3%
Q4 2020$13,136,000
-7.4%
755,823
-2.3%
0.00%0.0%
Q3 2020$14,191,000
-1.8%
773,746
-4.4%
0.00%0.0%
Q2 2020$14,454,000
+14.2%
809,305
+3.7%
0.00%
-25.0%
Q1 2020$12,661,000
-9.7%
780,594
+0.3%
0.00%
+33.3%
Q4 2019$14,019,000
-12.6%
778,631
-1.6%
0.00%
-25.0%
Q3 2019$16,031,000
+4.2%
791,226
+13.6%
0.00%0.0%
Q2 2019$15,392,000
+69.8%
696,453
+4.8%
0.00%
+100.0%
Q1 2019$9,065,000
+54.0%
664,619
+2.2%
0.00%0.0%
Q4 2018$5,888,000
-46.0%
650,544
-1.6%
0.00%
-33.3%
Q3 2018$10,910,000
+37.5%
661,168
+16.7%
0.00%
+50.0%
Q2 2018$7,934,000
+50.4%
566,700
+18.7%
0.00%
+100.0%
Q1 2018$5,274,000
+27.9%
477,300
+1.9%
0.00%0.0%
Q4 2017$4,124,000
-34.1%
468,540
-0.0%
0.00%
-50.0%
Q3 2017$6,256,000
-6.1%
468,668
+1.0%
0.00%0.0%
Q2 2017$6,660,000
-22.8%
464,056
+13.8%
0.00%0.0%
Q1 2017$8,628,000
-14.2%
407,934
+14.2%
0.00%
-33.3%
Q4 2016$10,055,000
-0.7%
357,191
-5.5%
0.00%0.0%
Q3 2016$10,123,000
+66.0%
378,017
+4.7%
0.00%
+50.0%
Q2 2016$6,099,000
+7.1%
361,095
+34.1%
0.00%0.0%
Q1 2016$5,695,000
-7.0%
269,180
+0.9%
0.00%0.0%
Q4 2015$6,124,000
+17.8%
266,732
+2.8%
0.00%0.0%
Q3 2015$5,199,000
+67.0%
259,396
+140.8%
0.00%
+100.0%
Q2 2015$3,114,000
+13.0%
107,715
+19.6%
0.00%0.0%
Q1 2015$2,755,000
+141.2%
90,098
+28.7%
0.00%
Q4 2014$1,142,00069,9890.00%
Other shareholders
COHERUS BIOSCIENCES INC shareholders Q3 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 568,408$2,125,84618.08%
CM Management, LLC 548,000$2,049,5202.18%
AlphaCentric Advisors LLC 912,500$3,412,7501.94%
Knott David M Jr 630,000$2,3560.90%
COURAGE CAPITAL MANAGEMENT LLC 50,000$1870.63%
Bridge City Capital, LLC 276,224$1,033,0780.52%
Kohlberg Kravis Roberts & Co. L.P. 3,036,076$11,354,9240.40%
Ikarian Capital, LLC 865,787$3,238,0430.39%
Aristotle Capital Boston, LLC 2,342,977$8,762,7340.28%
TANG CAPITAL MANAGEMENT LLC 400,000$1,496,0000.21%
View complete list of COHERUS BIOSCIENCES INC shareholders